Characteristics and six-month outcomes in a cohort of 8288 diabetic and non-diabetic patients with previous history of acute coronary syndrome or stroke: The French PREVENIR 3 survey

Diabetes and Metabolism

Volumn 32, Issue 5, 2006, Pages 460-466

  Bouhanick, B ^a   Cambou, J P ^b   Ferrieres J ^b   Amelineau, E ^c   Guize, L ^d  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

^c BRISTOL MYERS SQUIBB   (United States)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Acute coronary syndrome; Diabetes mellitus; Ischemic stroke; Secondary prevention

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART INFARCTION; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; STROKE; UNSTABLE ANGINA PECTORIS;

EID: 33751544520     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70304-X     Document Type: Article

References (22)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Multiple risk factor intervention Trial Research Group: Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk factor Intervention Trial. Diabetes Care 1993;16:434-44.
2. UK Prospective Diabetes Study Group: Efficacity of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317:713-20.
3. Rytter L, Troelsen S, Nielsen HB. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985;8:230-4.
4. Danchin N, Grenier O, Ferrieres J, Cantet C, Cambou JP. Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey. Heart 2002;88:159-62.
5. Amar J, Chamontin B, Ferrieres J, et al. Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis - the PREVENIR study. Heart 2002;88:587-91.
6. Cambou JP, Guize L, Cantet C, Amelineau E, Ferrieres J. Prognosis at six months for primary care patients: prognostics factors analysis. Ann Cardiol Angeiol 2005;54 (Suppl. 1):S2-9.
7. Ferrieres J, Cambou JP, Cantet C, Guize L. Prognosis at six months for coronary patients: impact of antiplatelet agents and statins. Ann Cardiol Angeiol 2005;54 (Suppl. 1):S10-6.
8. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
9. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998;21(suppl):S5-S19.
10. Petrie JC, O'Brien ET, Little WA, De Swiet M. Recommendations on blood pressure measurements. Br Med J 1986;293:611-5.
11. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension. Guidelines for the Management of Hypertension.. J Hypertens 1999;17:151-83.
12. Resnick HE, Shorr RI, Kuller L, Franse L, Harris TB. Prevalence and clinical implications of American Diabetes Association-defined diabetes and other categories of glucose dysregulation in older adults. J Clin Epidemiol 2001;54:869-76.
13. Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA 2004;292:2495-9.
14. Kaplan RC, Heckbert SR, Furberg CD, Psaty BM. Predictors of subsequent coronary events, stroke and death among survivors of forst hospitalised myocardial infarction. J Clin Epidemiol 2002;55:654-64.
15. Ledru F, Ducimetière P, Battaglia S, et al. New diagnostic criteria for diabetes and coronary artery disease : insights from an angiographic study. J Am Coll Cardiol 2001;37:1543-50.
16. Vickrey BG, Rector TS, Wickstrom SL, et al. Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke 2002;33:901-6.
17. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care 2004;27:201-7.
18. Corpus RA, George PB, House JA, et al. Optimal glycemic control is associated with lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 2004;43:8-14.
19. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997;314:1512-5.
20. Baird TA, Parsons MW, Barber A, et al. The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci 2002;9:618-26.
21. PROGRESS collaborative group. Randomised trial of a perindopril based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001;358:1033-41.
22. Mazoyer E, Drouet L, Soria C, et al. Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. Thromb Res 1999;95:163-76.